Release
📈 Stocks
Patronus Biotech Secures Approval for Phase I Malaria Vaccine Clinical Trial
(just now)
Patronus Biotech advances its malaria vaccine pipeline after receiving regulatory approval for a Phase I human trial in Australia targeting two primary…